focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentamin PLC Regulatory News (CEY)

Share Price Information for Centamin PLC (CEY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 127.00
Bid: 126.70
Ask: 126.90
Change: -1.10 (-0.86%)
Spread: 0.20 (0.158%)
Open: 126.80
High: 127.30
Low: 126.10
Prev. Close: 127.00
CEY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 OPD Centamin

16 Dec 2019 11:07

RNS Number : 9911W
Centamin PLC
16 December 2019
 

FOR IMMEDIATE RELEASE

 

16 December 2019

 

 

 

 

Centamin plc 

("Centamin" or "the Company")

(LSE:CEY, TSX:CEE)

 

 

 

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Centamin plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

-

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Centamin plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

13 December 2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES (Endeavour Mining Corporation)

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

ORDINARY SHARES

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests in Centamin plc's (Centamin) ordinary shares held by the directors of Centamin, their close relatives and related trusts and other concert parties:

 

Class of relevant security:

ORDINARY SHARES

Director

No. of Centamin ordinary shares held

Percentage of issued share capital

Josef El-Raghy and close relatives

10,500,000

0.908%

Other El-Raghy family members

579,212

0.050%

Andrew Pardey

2,295,268

0.199%

Ross Jerrard

350,000

0.030%

Gordon Edward Haslam

127,056

0.01%

Professor Ibrahim Fawzy

Nil

-

Dr. Sally Eyre

Nil

-

Mark Bankes

190,000

0.016%

Mark Arnesen

49,000

0.004%

Dr. Catharine Farrow

Nil

-

Marna Cloete

15,000

0.001%

 

(b) Awards in Centamin ordinary shares held by the directors of Centamin, their close relatives and related trusts and other concert parties:

 

(i) Ross Jerrard

 

Number of ordinary shares to vest

Date of grant

Exercise price

Vesting date

Scheme type - award under the Performance Share Plan (subject to performance conditions)

420,000

June 2017

Nil

June 2020

510,000

June 2018

Nil

June 2021

617,000

June 2019

Nil

June 2022

 

(ii) Andrew Pardey

 

Number of ordinary shares to vest

Date of grant

Exercise price

Vesting date

Scheme type - award under the Performance Share Plan (subject to performance conditions)

440,000

June 2017

Nil

June 2020

640,000

June 2018

Nil

June 2021

777,000

June 2019

Nil

June 2022

 

 

 

 

(iii) Other El-Raghy family members

 

Number of ordinary shares to vest

Date of grant

Exercise price

Vesting date

Scheme type - award under the Performance Share Plan (subject to performance conditions)

108,000

June 2017

Nil

June 2020

166,000

June 2018

Nil

June 2021

198,000

June 2019

Nil

June 2022

 

(c) Interests, short positions and rights to subscribe in Centamin's ordinary shares held by connected advisers of Centamin

 

BMO Capital Markets Limited:

 

Class of relevant security:

 

ORDINARY SHARES

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,022,958

0.26

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

3,022,958

0.26

Nil

-

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

16 December 2019

Contact name:

Darren Le Masurier

Telephone number:

+44 (0)1534 828700

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

Enquiries

For further information, please visit the website www.centamin.com or contact:

 

Centamin plc

Ross Jerrard, Chief Executive Officer

Alexandra Carse, Investor Relations

alexandra.carse@centamin.je

 

Buchanan

Bobby Morse

Chris Judd

centamin@buchanan.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEUNRARKRAUAAA
Date   Source Headline
21st Dec 20203:39 pmRNSNotification of Major Holding(s)
10th Dec 202012:30 pmRNSDirector Declaration
8th Dec 20207:00 amRNSDirector/PDMR Shareholding
7th Dec 20207:00 amRNSDirector/PDMR Shareholding
2nd Dec 20207:00 amRNSUnlocking Centamin’s Potential – Market Event
2nd Dec 20207:00 amRNSOpen Pit Contract Award
25th Nov 20207:00 amRNSNOTIFICATION OF CAPITAL MARKETS EVENT
20th Nov 20207:11 amRNSNotification of Major Holding(s)
19th Nov 20204:40 pmRNSNotification of Major Holding(s)
18th Nov 20207:00 amRNSDirector Declaration
2nd Nov 20202:30 pmRNSDirector Declaration
29th Oct 20207:00 amRNSAppointment of Joint Corporate Broker
21st Oct 20207:00 amRNSQ3 2020 Report
7th Oct 20207:00 amRNSNOTICE OF DIRECTOR DEALING
6th Oct 20207:00 amRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSSukari Operational Update
2nd Sep 202012:00 pmRNSDirector/PDMR Shareholding
14th Aug 20207:00 amRNSNotice of New Website
4th Aug 20207:01 amRNS2020 Interim Results
4th Aug 20207:00 amRNSDividend Declaration
13th Jul 20207:00 amRNSQ2 2020 Report
7th Jul 20202:26 pmRNSNotification of Major Holding(s)
29th Jun 20202:34 pmRNSResult of 2020 Annual General Meeting
23rd Jun 20207:02 amRNS2019 Sustainability Report
23rd Jun 20207:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
9th Jun 20203:58 pmRNSNotification of Major Holding(s)
8th Jun 20207:00 amRNSDIRECTOR/PDMR SHARE AWARDS
8th Jun 20207:00 amRNSDIRECTOR/PDMR SHARE AWARDS
1st Jun 20207:13 amRNSAppointment of Non-Executive Director
27th May 20207:00 amRNSNotice of AGM & Publication of 2019 Annual Report
18th May 20207:01 amRNSPayments to Governments Report
18th May 20207:00 amRNSAnnual Results for the year ended 31 December 2019
18th May 20207:00 amRNSAnnual Results for the year ended 31 December 2019
11th May 20209:00 amRNSNotification of Full Year 2019 Results
11th May 20207:00 amRNSDirector Declaration
27th Apr 20207:00 amRNSDisclosure of Rights attached to Equity Shares
21st Apr 20207:00 amRNSQuarterly Report and Dividend Declaration
20th Apr 20205:34 pmRNSNOTIFICATION OF MAJOR HOLDINGS
6th Apr 20207:01 amRNSNOTIFICATION OF MAJOR HOLDINGS
6th Apr 20207:00 amRNSDonation towards Egypt’s COVID-19 Relief Efforts
2nd Apr 20207:00 amRNSAppointment of CEO
25th Mar 20207:00 amRNSFCA Results Guidance and COVID-19 Update
24th Mar 20209:14 amRNSNotification of Major Holdings
25th Feb 20203:15 pmRNSForm 8.3 - Centamin PLC
21st Feb 20207:00 amRNSForm 8.3 - Centamin PLC
17th Feb 20207:00 amRNSForm 8.3 - Centamin PLC
7th Feb 20204:29 pmRNSForm 8.3 - Centamin PLC
4th Feb 202010:30 amRNSNotification of Major Holding(s)
30th Jan 20207:00 amRNSQ4 2019 Results
29th Jan 20207:00 amRNSForm 8.3 - Centamin PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.